Charles A. Deignan, Chief Financial Officer at Clearside Biomedical, Inc. (CLSD), bought 1,000 shares at $7.07 ($7K) on 2017-08-14, disclosed to the SEC on 2017-08-14.
Open-market purchase of $7k CLSD by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CLSD | SELL | 2022-01-20 | $18K | — | Filing → |
| CLSD | SELL | 2021-09-23 | $18K | — | Filing → |
| CLSD | SELL | 2021-06-23 | $13K | — | Filing → |